Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings

On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted NDA submission in 2023 supported by MMS Holdings MMS Holdings, which specializes in supporting first-in-class NDAs, was selected for extensive experience in neuroscience

MicrobioSeq Boosts Microbial Diversity Research with Eukaryotic 18S rRNA Sequencing

Amerigo Scientific Announces the Launch of Extra Large Drying Traps

Amerigo Scientific introduces new extra large Drying Traps for research application.

Global Active Pharmaceutical Ingredients Market Is Expected To Grow With The CAGR Of More Than 6.8% By 2027

Global Active Pharmaceeutical Ingredients Market size, share, trends, growth, opportunity, forecast

5th Edition of World Nanotechnology Conference

CD BioSciences Announces Solubilization and Stabilization Solution to Simplify GPCR Research

CD BioSciences introduces GPCR solubilization and stabilization services to researchers to advance scientific programs in GPCR research and drug development.

STEMart Launches Microbiology & Sterility Testing Services for Medical Devices

STEMart introduces comprehensive microbiology and sterility testing for sterile, non-pyrogenic products.

Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety

Creative Diagnostics introduced CC50/IC50 testing services with a high level of detection sensitivity and accuracy.

Jumo Health Helps Young People to Become Effective Patient Advocates

Jumo Health, a global provider of age appropriate, culturally sensitive, medical education resources, today announced that it is extending its ongoing support of the International Children’s Advisory Network (iCAN), a global consortium of youth advisory groups. iCAN empowers pediatric patients worldwide and provides a voice for children and their families in healthcare, clinical trials, and medical research.

Fuel Cell Catalysts for Renewable Energy Industry

CD Formulation Enables Customized Synthesis Service for Osmotic Pressure Regulators

Normal cell function requires the maintenance of osmotic pressure. Therefore, in drug manufacturing, osmotic pressure regulators should be added to the formulation to avoid tissue damage. The US-based CRO company CD Formulation recently announced its ability to synthesize osmotic pressure regulators to suit the needs of different drug projects. These osmotic pressure regulators will help parenteral preparations to keep isotonic with human plasma.

Creative Enzymes Introduces DNA Modifying Enzymes for Molecular Biology Research

Creative Enzymes Expands Its Service Offering with the Launch of Native Horseradish Peroxidase

mdgroup Proudly Sponsors Gladiator Project Spring Classic Golf Fundraiser to Raise Awareness and Hope for Brain Cancer Research and Support

mdgroup Proudly Sponsors Gladiator Project Spring Classic Golf Fundraiser to Raise Awareness and Hope for Brain Cancer Research and Support Durham, NC, USA – 21 June 2022 – mdgroup, the global digital and patient servicing company pioneering a patient-first approach to clinical research, is proud to sponsor brain cancer research and patient support group, Gladiator Project, with its upcoming Spring Classic golf tournament in the USA. Taking place in New Jersey on June 27 at the Plainfield Country Club in Edison, the sporting event will attract audiences from the patient advocacy community, as well as the research industry, including mdgroup Chief Operating Officer, LaQuinta Jernigan.

ZeOmega Announces Agreement with HealPros to Optimize In-Home Experiences for People with Chronic Illness: ZeOmega’s Jiva Platform to Support HealPros New In-Home Program Deployment

ZeOmega®, the leading population health management organization, has partnered with HealPros, a healthcare services company that works with some of the largest health plans in the nation to build and deliver programs that change the lives of people with chronic illnesses. This partnership will yield significant results for health plans and their members by helping them access personalized care and delivering in-home experiences people love.

Optibrium receives further investment from Kester Capital

Optibrium™, a developer of software for drug discovery, today announced it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm. Funding will further drive company expansion and commercial growth of its AI-enabled drug discovery technology.

Global Biologics Consulting Services Market is poised to witness a CAGR of >15%, driven by the growing biopharmaceutical market

The biologics consulting services market is driven by increasing R&D in advanced therapies like cell & gene therapies, growing biologics regulatory approvals and significant VC fundings for biologics segment.

ChargePoint Technology’s new facility expands into Europe

Single Use Bioprocess System Market is expected to exhibit a CAGR of close to 20% over the forecast period 2020 – 2030

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Biopharma PEG Provides Monodisperse PEGs In Drug Development

The team of Biopharma PEG Scientific Inc. owns the most qualified and talented synthetic and medicinal chemists. We can provide a wide range of high purity monodispersed PEG products of multi functionalized groups in milligram to hundreds of kilograms or greater with GMP standard manufacturing capability.